Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 7.25 Contact Hours.
June 24, 2017
New York, NY
The Westin New York at Times Square
270 West 43rd St (at 8th Avenue)
New York, NY
The 1st Annual International Congress on Oncology Pathology™: Towards Harmonization of Pathology and Oncology Standards will provide the latest information on key topics in pathology that can readily be applied to clinical practice in a variety of settings. This event will bring together oncologists and pathologists to facilitate awareness of recent advancements in the field of cancer pathology and enhance multidisciplinary collaboration. Leading experts will address critical topics in pathology screening for malignancies commonly encountered in clinical practice. From a foundation of tumor-specific discussions, our clinical experts will appraise clinical guidelines, explore new concepts and clinical research, and address obstacles to optimizing practice. This will be a dynamic experience, allowing participants to engage with faculty as they share their perspectives and personal experiences on clinical challenges and ongoing controversies in the field of pathology. A variety of formats will be used to generate an exciting learning environment, including cutting-edge lectures, panel discussions, multidisciplinary tumor boards, and interactive question-and-answer sessions.
This educational program is directed toward pathologists and oncologists interested in the management of patients with cancer. Fellows, residents, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of patients with cancer are also invited to attend.
Upon completion of this activity, participants should have improved their ability to:
- Describe recent advancements in the understanding of the pathogenesis and relevant biomarkers of commonly-encountered malignancies
- Select evidence-based molecular and cytogenetic testing strategies for commonly-encountered malignancies
- Compare the roles of genomic and targeted assays in patient management
- Develop multidisciplinary strategies to optimize cancer diagnosis and management
- Apply current clinical trial data in cancer pathology to the tailoring of patient treatment protocols
Co-ChairsAlain Borczuk, MD
Professor of Pathology and Laboratory Medicine
Vice Chairman for Anatomic Pathology
Department of Pathology and Laboratory Medicine
Weill Cornell Medicine
New York, NY
Balazs Halmos, MD
Professor of Clinical Medicine
Director, Thoracic Oncology
Director, Clinical Cancer Genomics
Albert Einstein College of Medicine/Montefiore Medical Center